uce
ProgressImage ProgressImage
Astrazeneca Pharma India Ltd
Pharmaceuticals - Multinational
BSE Code 506820 border-img ISIN Demat INE203A01020 border-img Book Value 261.99 border-img NSE Symbol ASTRAZEN border-img Div & Yield % 0.29 border-img Market Cap ( Cr.) 13561.13 border-img P/E 85.02 border-img EPS 63.8 border-img Face Value 2
Quarters
ParticularsDec 2023
()
Sep 2023
()
Jun 2023
()
Gross Sales305.79311.07295.46
Other Operating Income0.000.000.00
Other Income 9.6624.808.10
Total Income315.45335.87303.56
Total Expenditure 290.73258.31228.21
PBIDT24.7277.5675.35
Interest 0.610.500.15
PBDT24.1077.0675.20
Depreciation3.703.673.80
Tax4.6521.2917.47
Fringe Benefit Tax0.000.000.00
Deferred Tax-0.06-0.280.07
Reported Profit After Tax15.8052.3753.86
Extra-ordinary Items 0.0011.660.00
Adjusted Profit After Extra-ordinary item15.8040.7153.86
    
EPS (Unit Curr.)6.3220.9521.54
EPS (Adj) (Unit Curr.)6.3220.9521.54
Calculated EPS (Unit Curr.)6.3220.9521.54
Calculated EPS (Adj) (Unit Curr.)6.3220.9521.54
Calculated EPS (Ann.) (Unit Curr.)25.2883.7986.18
Calculated EPS (Adj) (Ann.) (Unit Curr.)25.2883.7986.18
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity5.005.005.00
Reserve & Surplus0.000.000.00
Face Value2.002.002.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)8.0824.9325.50
PBDTM(%)7.8824.7725.45
PATM(%)5.1716.8418.23
x
x
×
Let's Chat
close
refresh